Longevity Summit Dublin CEO Martin O’Dea on why Dublin is becoming a new frontier in healthspan innovation and investment.
The longevity sector continues to evolve from promising research to practical applications, and this year’s Longevity Summit Dublin reflects that maturation. Taking place from July 2 to 4 at Trinity College Dublin, our 2025 summit brings together over 500 attendees from across the scientific and commercial spectrum. This gathering represents a unique convergence of disciplines, bringing together academic researchers, medical professionals, business leaders and industry innovators. The diversity isn’t coincidental; it reflects the interdisciplinary nature of longevity science, where breakthroughs often emerge at the intersection of different fields.
The Trinity Business School, with its three main theaters and state-of-the-art facilities, provides an ideal setting for this convergence. The venue offers the Dargan Theatre and Maharry, all equipped with full AV capabilities, podcasting facilities and complete wheelchair accessibility. The choice of Trinity College Dublin is particularly significant, as it represents the academic-industry bridge that defines modern longevity research. Here, centuries-old academic tradition meets cutting-edge innovation. It’s where theoretical breakthroughs transform into practical applications that can extend healthspan and improve quality of life for millions. The university’s commitment to accessibility and modern technology ensures that all attendees can fully participate in the scientific discourse.
What makes Ireland’s emergence as a longevity hub particularly fascinating is the speed of transformation. Just five years ago, longevity was a niche field dominated by Silicon Valley entrepreneurs and a handful of academic institutions. Today, it’s a multi-billion-dollar industry attracting pharmaceutical giants, tech companies and governments worldwide. Ireland has positioned itself strategically within this ecosystem, leveraging its strengths in biotechnology, data analytics and clinical research.
The 2025 summit reflects the maturation of the field. We’re moving beyond the early days of ambitious promises to evidence-based interventions. Our program addresses the most pressing questions in longevity science: how do we translate laboratory discoveries into clinical applications? What role will artificial intelligence play in personalized longevity medicine? How do we ensure that longevity interventions are accessible and equitable?
One of our most significant additions this year is the Women’s Health & Longevity pre-event on July 1st. This isn’t just about addressing a research gap, it’s about recognizing that longevity science has historically overlooked half the population. The gender-specific aspects of aging, from hormonal influences to autoimmune responses, require dedicated attention. Our pre-event, featuring leading researchers and clinicians, aims to accelerate progress in this critical area.
The integration of AI and decentralized science represents another frontier we’re exploring. Traditional research models, while rigorous, can be slow and expensive. Decentralized approaches, powered by artificial intelligence, offer the potential to democratize research and accelerate discovery. We’re seeing early examples of this in biomarker development, drug discovery and clinical trial design.
What excites me most about our speaker lineup is the balance between established leaders and emerging voices. We have researchers, like Brian Kennedy, Rozalyn Anderson, Matt Kaeberlein and Jennifer Garrison, who’ve spent decades studying the fundamental mechanisms of aging alongside leaders in the field who are translating these discoveries into commercial applications, such as Yuta Lee, Lou Hawthorne and Patrick Sewell. This combination creates a dynamic environment where theoretical insights meet practical implementation.
The economic implications of Ireland’s longevity focus extend far beyond the conference itself. We’re witnessing the emergence of a new industry cluster, with startups, established companies and research institutions choosing Dublin as their European base. The combination of English-speaking talent, EU market access and supportive government policies creates an attractive environment for longevity companies.
From a scientific perspective, the timing couldn’t be better. We’re at an inflection point where multiple technologies; genomics, proteomics, artificial intelligence and advanced therapeutics, are converging to make meaningful longevity interventions possible. The question is no longer whether we can extend healthy human lifespan, but how quickly we can develop safe and effective interventions.
The summit’s focus on practical applications reflects this shift. Attendees won’t just hear about promising research; they’ll learn about interventions they can implement today. From lifestyle modifications backed by rigorous science to emerging therapeutic approaches entering clinical trials, the content is designed to bridge the gap between research and practice.
Looking ahead, I see Ireland’s role in the longevity ecosystem continuing to expand. The combination of world-class research institutions, a supportive regulatory environment and growing industry presence creates a foundation for sustained growth. The connections forged at our summit, between researchers and entrepreneurs, between Irish companies and international partners, will drive this expansion.
With an emphasis on evidence-based interventions and cross-sector collaboration, the conversations at Trinity College are poised to revolutionise the translation of research into impactful health solutions. This engaging three-day program is designed to foster meaningful networking, encourage vibrant knowledge exchange, and cultivate partnerships that will propel the field of longevity science forward. It’s also an opportunity for professional development, fostering ambition and drive. Join us for an inspiring journey towards innovative health advancements.
Sláinte!
Longevity Summit Dublin runs 2–4 July at Trinity Business School in Dublin. For tickets and more information CLICK HERE.
About Martin O’Dea
Martin O’Dea is CEO of Longevity Events Limited and Applied Longevity Intelligence Services (ALIS), and the driving force behind the annual Longevity Summit Dublin. With over a decade of experience in the longevity space, he is an author and one of the early contributors to the International Longevity Alliance.
Martin’s interests span human advancement through both technological and biological innovation.
